Advertisement
For people living with HIV

Expected Burden of Lung Cancer High for People Living With HIV

0
PLWH who adhere to antiretroviral tx but smoke are substantially more likely to die from lung cancer
Postmarketing adverse events related to the CardioMEMS HF System are infrequent

Postmarketing Adverse Events Low for CardioMEMS HF System

0
Of the 5,500 implants during the first three years after FDA approval, 155 reports described 177 events
Hospital quality contributes to readmission rates independent of factors involving patients

Hospital Quality Independently Impacts Readmission Rates

0
Readmission rates differ for patients with similar diagnoses admitted to best versus worst hospitals
Spin in biomedical literature (also referred to as "science hype") is prevalent

‘Science Spin’ Found Prevalent in Biomedical Literature

0
Nature of spin varies, with highest variability in prevalence of spin seen in trials
Physicians spend almost six hours per day in the electronic health record

Doctors Spend Almost Six Hours Per Day on EHR Tasks

0
Clerical and administrative tasks including order entry, billing account for almost half of hours
Most physicians on Twitter with a financial conflict of interest and frequent tweets mention specific drugs for which they have a conflict

Physicians Tweeting About Drugs May Have Conflict of Interest

0
Physicians with financial conflict of interest often mention specific drugs for which they have a conflict
An automated molecular assay can detect Mycobacterium tuberculosis with resistance to drugs directly from sputum specimens

Assay Can ID M. tuberculosis Resistance Mutations

0
Assay detects mutations associated with resistance to isoniazid, fluoroquinolones, aminoglycosides
The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration.

FDA Approves First Biosimilar Drug for Cancer

0
Mvasi (bevacizumab-awwb) is biosimilar to Avastin
For patients with atrial fibrillation with two or more failed pulmonary vein isolation procedures

Ablating Non-Pulmonary Vein Triggers Improves A-Fib Outcome

0
Success rate 81 percent for those with, 8 percent for those without non-pulmonary vein ablation
The age-adjusted U.S. cancer death rate decreased 25 percent from 1991 to 2014

AACR Releases 2017 Cancer Progress Report

0
Twenty-five percent decrease in age-adjusted U.S. cancer death rate from 1991 to 2014